We are live on
!
Find out more
CAM
Cresset Asset Management Portfolio holdings
AUM
$23.1B
1-Year Est. Return
27.04%
This Fund
S&P 500
This Quarter
Est. Return
+0.15%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$373M
(+5.3%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
5.12%
Top 10 Holdings %
Top 10 Hldgs %
62.33%
Holding
1,161
New
145
Increased
742
Reduced
165
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Innovation ETF
ARKK
|
+$55.7M |
| 2 |
iShares Gold Trust
IAU
|
+$31.5M |
| 3 |
Hyatt Hotels
H
|
+$22.1M |
| 4 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$18M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$15.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$20.2M |
| 2 |
Celldex Therapeutics
CLDX
|
+$15.3M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$9.52M |
| 4 |
Palantir
PLTR
|
+$4.79M |
| 5 |
RTX Corp
RTX
|
+$4.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.28% |
| 2 | Consumer Discretionary | 6.79% |
| 3 | Healthcare | 3.4% |
| 4 | Financials | 3.36% |
| 5 | Communication Services | 2.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONEM
1026
DELISTED
1Life Healthcare
ONEM
| $206K | ﹤0.01% |
10,178
-522
| -5% | -$13.4K |
|
1027
GDS Holdings
GDS
$6.41B
| $203K | ﹤0.01% |
3,592
-87
| -2% | -$5.36K |
|
1028
Nomura Holdings
NMR
$29.1B
| $203K | ﹤0.01% |
41,206
+8,643
| +27% | +$43.2K |
|
1029
Dorman Products
DORM
$4.18B
| $202K | ﹤0.01% |
2,135
+63
| +3% | +$6.21K |
|
1030
Iron Mountain
IRM
$36.1B
| $202K | ﹤0.01% |
+4,603
| New | +$207K |
|
|
GTM
1031
ZoomInfo Technologies
GTM
$1.22B
| $202K | ﹤0.01% |
+3,300
| New | +$197K |
|
1032
Brookfield Renewable
BEP
$9.96B
| $201K | ﹤0.01% |
+5,442
| New | +$211K |
|
1033
Bruker
BRKR
$8.14B
| $201K | ﹤0.01% |
+2,572
| New | +$214K |
|
1034
Cenovus Energy
CVE
$52.1B
| $200K | ﹤0.01% |
19,882
+7,534
| +61% | +$64.3K |
|
1035
Selective Insurance
SIGI
$5.73B
| $200K | ﹤0.01% |
+2,655
| New | +$214K |
|
|
HBI
1036
DELISTED
Hanesbrands
HBI
| $199K | ﹤0.01% |
+11,584
| New | +$217K |
|
|
SGMO
1037
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $197K | ﹤0.01% |
21,855
+44
| +0.2% | +$435 |
|
1038
Wipro
WIT
$20B
| $196K | ﹤0.01% |
44,246
+286
| +0.7% | +$1.25K |
|
1039
Cemex
CX
$16.3B
| $195K | ﹤0.01% |
27,228
+4,183
| +18% | +$33K |
|
1040
VanEck Vietnam ETF
VNM
$504M
| $193K | ﹤0.01% |
10,000
-250
| -2% | -$4.91K |
|
1041
Anavex Life Sciences
AVXL
$310M
| $190K | ﹤0.01% |
+10,554
| New | +$210K |
|
|
EMBJ
1042
Embraer S.A. ADS
EMBJ
$13B
| $184K | ﹤0.01% |
+10,827
| New | +$168K |
|
|
HFRO
1043
Highland Opportunities and Income Fund
HFRO
$407M
| $183K | ﹤0.01% |
+17,000
| New | +$182K |
|
1044
ICL Group
ICL
$6.85B
| $183K | ﹤0.01% |
25,181
+1,235
| +5% | +$8.72K |
|
|
XHR
1045
Xenia Hotels & Resorts
XHR
$1.79B
| $182K | ﹤0.01% |
10,279
+63
| +0.6% | +$1.1K |
|
|
BPMP
1046
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $182K | ﹤0.01% |
+13,725
| New | +$185K |
|
1047
Lumen
LUMN
$6.44B
| $179K | ﹤0.01% |
14,406
+2,817
| +24% | +$35.3K |
|
1048
Gates Industrial Corporation Ltd.
GTES
$7.15B
| $170K | ﹤0.01% |
+10,465
| New | +$179K |
|
1049
Nokia
NOK
$52.3B
| $168K | ﹤0.01% |
30,933
+2,930
| +10% | +$17K |
|
|
HIVE
1050
HIVE Digital Technologies
HIVE
$777M
| $164K | ﹤0.01% |
+12,285
| New | +$172K |
|
Similar funds
CHP
FAM
OAG
BA
Cresset Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, Cresset Asset Management held 1,161 positions worth $7.43B, up 5.3% from $7.06B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Cresset Asset Management deployed $381M of net new capital in Q3 2021, opening 145 new positions and adding to 742 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $20.2M trimmed.
- Cresset Asset Management's largest Q3 2021 buy was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
- Cresset Asset Management added most to ARK Innovation ETF in Q3 2021, an estimated $55.7M increase.
- Cresset Asset Management's biggest Q3 2021 reduction was Apple, cutting an estimated $20.2M.
- Cresset Asset Management fully exited Celldex Therapeutics in Q3 2021, selling an estimated $15.3M.
- Cresset Asset Management's ten largest holdings make up 62% of its $7.43B portfolio in Q3 2021.
- Cresset Asset Management opened 145 new positions and closed 58 in Q3 2021.
- Cresset Asset Management's portfolio value rose 5.3% quarter-over-quarter to $7.43B.
Based on Cresset Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.